ONE YEAR FOLLOW-UP OF PATIENTS WITH TYPE 1 AND TYPE 2 DIABETES TREATED WITH INSULIN GLARGINE U300 IN CLINICAL PRACTICE

被引：0
|
作者：
Bramlage, P. [1 ]
Lanzinger, S. [2 ]
Danne, T. [3 ]
Muehldorfer, S. [4 ]
Hess, G. M.
Naudorf, M. [5 ]
Holl, R. [2 ]
机构：
[1] Inst Pharmacol & Prevent Med, Mahlow, Germany
[2] Univ Ulm, Inst Epidemiol & Med Biometry ZIBMT, Ulm, Germany
[3] Childrens Hosp, BULT Diabetol Endocrinol Gastroenterol & Clin Res, Hannover, Germany
[4] Klinikum Bayreuth GmbH, Gastroenterol Clin, Bayreuth, Germany
[5] Diabet Ctr Lindlar, Med Practice, Lindlar, Germany
来源：
DIABETES TECHNOLOGY & THERAPEUTICS | 2019年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
095
引用
收藏
页码：A43 / A43
页数：1
相关论文
共 50 条
  • [31] Changes in HbA1c and hypoglycemic episodes in type 1 diabetes patients after switching to insulin glargine U300: Pilot study
    Gradiser, Marina
    Berkovic, Maja Cigrovski
    Bilic-Curcic, Ines
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2017, 129 : 144 - 147
  • [32] Real-World Use of Insulin Glargine U100 and U300 in Insulin-Naïve Patients with Type 2 Diabetes Mellitus: DosInGlar Study
    Natalia Duque
    Esther Artime
    Irene Romera
    Jeremie Lebrec
    Silvia Díaz
    Miriam Rubio
    Antoni Sicras-Mainar
    Enrique Carretero-Anibarro
    Xavier Mundet
    Juan J. Gorgojo-Martínez
    Jesús Reviriego
    Advances in Therapy, 2021, 38 : 3857 - 3871
  • [33] Effects of Insulin Degludec and Insulin Glargine U300 on Interday Glycemic Variability in Individuals with Type 1 Diabetes: A Multicenter, Randomized, Crossover Study
    Miura, Hiroshi
    Sakaguchi, Kazuhiko
    Kaneko, Akihiro
    Ito, Jun
    Morita, Yasuko
    Yamada, Tomoko
    Otowa-Suematsu, Natsu
    So, Anna
    Nakamura, Tomoaki
    Komada, Hisako
    Okada, Yuko
    Hirota, Yushi
    Tamori, Yoshikazu
    Ogawa, Wataru
    DIABETES, 2020, 69
  • [34] One-year follow-up of antihypertensive patients with type 2 diabetes mellitus
    Girerd, X
    Fontaine, P
    Herpin, D
    Moulin, B
    Desriac, I
    Marie, P
    Allaert, FA
    JOURNAL OF HYPERTENSION, 2004, 22 : S127 - S127
  • [35] Insulin glargine u300 versus insulin degludec around spontaneous exercise sessions in people with type 1 diabetes: the Ultraflexi-1 study
    Sourij, H.
    Mueller, A.
    Aberer, F.
    Aziz, F.
    Kojzar, H.
    Sourij, C.
    Obermayer, A.
    Abbas, F.
    Eckstein, M. L.
    Lenz, J.
    Sternad, C.
    Pferschy, P. N.
    Tripolt, N. J.
    Ziko, H.
    Moser, O.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S220 - S221
  • [36] A comparison of Insulin Glargine U300 and Insulin Degludec around spontaneous exercise sessions in people with type 1 diabetes - the ULTRAFLEXI-1 study
    Moser, Othmar
    Mueller, Alexander
    Aberer, Felix
    Aziz, Faisal
    Kojzar, Harald
    Sourij, Caren
    Obermayer, Anna
    Abbas, Farah
    Birnbaumer, Philipp
    Eckstein, Max
    Hoenger, Lukas
    Lenz, Jaqueline
    Mursic, Ines
    Sternad, Christoph
    Weber, Barbara
    Zanker, Matthias
    Ziko, Haris
    Pferschy, Peter
    Tripolt, Norbert
    Sourij, Harald
    WIENER KLINISCHE WOCHENSCHRIFT, 2022, 134 (SUPPL 4) : 251 - 251
  • [37] What does the insulin pump change in children with type 1 diabetes? One-year clinical follow-up
    Engin, Muhammet Mesut Nezir
    Arslanoglu, Ilknur
    Cangur, Sengul
    HORMONE RESEARCH IN PAEDIATRICS, 2019, 91 : 527 - 528
  • [38] Beneficial renal effect of insulin glargine 300 U/ml initiation in type 2 diabetes mellitus patients previously treated with insulin
    Popovic, D. S.
    Lelik-Tubic, K.
    DIABETES STOFFWECHSEL UND HERZ, 2020, 29 (06): : 364 - +
  • [39] Clinical Outcome Assessment of the Effectiveness of Insulin Degludec (Degludec) in Real-life Medical Practice (CONFIRM)-A Comparative Effectiveness Study of Degludec and Insulin Glargine 300U/mL (Glargine U300) in Insulin-Naive Patients with Type 2 Diabetes (T2D)
    Tibaldi, Joseph
    Haldrup, Steffen
    Sandberg, Viktor
    Wolden, Michael L.
    Rodbard, Helena W.
    DIABETES, 2018, 67
  • [40] More Physiological Circulating Insulin and Modulation of Hepatic Glucose Production with Insulin Glargine U300 vs. U100 in Type 1 Diabetes
    Porcellati, Francesca
    Lucidi, Paola
    Andreoli, Anna Marinelli
    Cioli, Patrizia
    Candeloro, Paola
    Bolli, Geremia B.
    Fanelli, Carmine G.
    DIABETES, 2017, 66 : A269 - A269
12345